Norges Bank Aurinia Pharmaceuticals Inc. Transaction History

Norges Bank

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$4.81 - $5.78 $548,556 - $659,180	114,045 New	114,045 $651,000
Q4 2023 Feb 09, 2024	BUY	$7.13 - $9.49 $813,140 - $1.08 Million	114,045 New	114,045 $1.03 Million
Q3 2023 Nov 13, 2024	BUY	$7.77 - $12.27 $886,129 - $1.4 Million	114,045 New	114,045 $886,000
Q3 2023 Nov 13, 2023	SELL	$7.77 - $12.27 $886,129 - $1.4 Million	-114,045 Closed	0 $0
Q2 2023 Aug 14, 2023	SELL	$8.96 - $11.69 $1.02 Million - $1.33 Million	-114,045 Closed	0 $0
Q1 2023 May 15, 2024	BUY	$5.94 - $11.27 $677,427 - $1.29 Million	114,045 New	114,045 $1.25 Million
Q4 2022 Feb 14, 2023	BUY	$4.11 - $8.14 $468,724 - $928,326	114,045 New	114,045 $492,000
Q3 2022 Nov 13, 2023	BUY	$6.66 - $12.39 $759,539 - $1.41 Million	114,045 New	114,045 $857,000
Q2 2022 Aug 14, 2023	BUY	$8.95 - $12.8 $1.02 Million - $1.46 Million	114,045 New	114,045 $1.15 Million
Q1 2021 May 07, 2021	SELL	$12.3 - $18.73 $466,981 - $711,103	-37,966 Closed	0 $0
Q4 2020 Mar 02, 2021	BUY	$12.94 - $16.05 $491,280 - $609,354	37,966 New	37,966 $525,000
Q4 2020 Feb 10, 2021	SELL	$12.94 - $16.05 $491,280 - $609,354	-37,966 Closed	0 $0
Q3 2020 Nov 12, 2021	BUY	$13.19 - $16.66 $500,771 - $632,513	37,966 New	37,966 $559,000

208

58.1M

1.14M

1.51M

Ticker AUPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,892,000
Market Cap $1.14B
Description
Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...

Get notified when there are updates to the investment portfolio of Norges Bank, based on Form 13F filings with the SEC.

Stay updated on Norges Bank with notifications on news.